Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GE HealthCare Technologies Inc.GEHC · Entity 1711 | Director | May 22, 2026 | May 26, 2026 |
| Parker-Hannifin CorpPH · Entity 2887 | Director | December 03, 2025 | December 05, 2025 |
| STRYKER CORPSYK · Entity 369 | Director · Chair and CEO | March 21, 2026 | March 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GE HealthCare Technologies Inc.
Report date May 22, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 14,363 |
Reported balance
After 2026-05-22 transaction · row 1
1 source rowRow 1 · 2026-05-22 · Purchase · Acquired 10,000 · Balance 14,363 |
Parker-Hannifin Corp
Report date December 03, 2025 · Filed December 05, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,824 |
Reported balance
After 2025-12-03 transaction · row 1
1 source rowRow 1 · 2025-12-03 · Gift · Disposed 2,048 · Balance 5,824 |
STRYKER CORP
Report date March 21, 2026 · Filed March 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 222,231 |
Ending reported balance
After 2026-03-21 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-21 · Exercise / conversion · Acquired 1,452 · Balance 248,723 F1: On March 11, 2026, the Reporting Person filed a Form 4 reporting the acquisition of 50,332 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2026 (the "Performance Stock Units"). The 1,452 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2026 and were settled for an equal number of shares of Stryker Common Stock. Row 2 · 2026-03-21 · Tax withholding · Disposed 26,492 · Balance 222,231 |
| Dividend EquivalentsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-03-21 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-03-21 · Exercise / conversion · Disposed 1,452 · Balance 0 F1: On March 11, 2026, the Reporting Person filed a Form 4 reporting the acquisition of 50,332 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2026 (the "Performance Stock Units"). The 1,452 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2026 and were settled for an equal number of shares of Stryker Common Stock. |
| Common StockSEC Table I · non-derivative | IndirectBy 401K | 721 |
Reported balance
Holding disclosure · report date 2026-03-21 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 721 |
Filing footnotes · ownership attribution and instrument terms
F1: On March 11, 2026, the Reporting Person filed a Form 4 reporting the acquisition of 50,332 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2026 (the "Performance Stock Units"). The 1,452 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2026 and were settled for an equal number of shares of Stryker Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2026 Filed May 26, 2026 22:44 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | PurchaseCommon Stock, par value $0.01 per share | 10,000 | $64.18 | $641,800.00 |
DisclosureSEC source: 0001519419-26-000011 · wk-form4_1779835492.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,363 Read SEC document |
| May 07, 2026 Filed May 12, 2026 00:10 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 3,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001519419-26-000009 · wk-form4_1778544646.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,363 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 21, 2026 Filed Mar 24, 2026 21:07 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionDividend Equivalents · Derivative | 1,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001519419-26-000007 · wk-form4_1774386464.xml · derivative · entry 4 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,452 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 11, 2026, the Reporting Person filed a Form 4 reporting the acquisition of 50,332 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2026 (the "Performance Stock Units"). The 1,452 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2026 and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.exercise_date: On March 11, 2026, the Reporting Person filed a Form 4 reporting the acquisition of 50,332 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2026 (the "Performance Stock Units"). The 1,452 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2026 and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.expiration_date: On March 11, 2026, the Reporting Person filed a Form 4 reporting the acquisition of 50,332 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2026 (the "Performance Stock Units"). The 1,452 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2026 and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 21, 2026 Filed Mar 24, 2026 21:07 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 26,492 | $335.67 | $8,892,569.64 |
DisclosureSEC source: 0001519419-26-000007 · wk-form4_1774386464.xml · nonDerivative · entry 2 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,231 Read SEC document |
| March 21, 2026 Filed Mar 24, 2026 21:07 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 1,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001519419-26-000007 · wk-form4_1774386464.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On March 11, 2026, the Reporting Person filed a Form 4 reporting the acquisition of 50,332 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2026 (the "Performance Stock Units"). The 1,452 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2026 and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 20:08 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 777 | $0.00 | $0.00 |
DisclosureSEC source: 0001519419-26-000006 · wk-form4_1773778094.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 777 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) March 13, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:58 UTC | STRYKER CORP SYK · Entity 369 | GrantCommon Stock | 50,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001519419-26-000002 · wk-form4_1773262689.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,271 F1 · kind: Acquired upon the achievement of pre-established three-year adjusted diluted net earnings per share goals and sales performance goals. The earned shares vest on March 21, 2026. F2 · balance_after: The balance of shares reflects an adjustment of one share from the amount previously reported to correct the number of shares that were withheld to cover the option exercise cost and tax withholding that occurred on February 6, 2026. Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 21:18 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 02/10/2016 (right to buy) · Derivative | 206,955 | $0.00 Strike: $96.64 | $0.00 |
DisclosureSEC source: 0001519419-26-000001 · wk-form4_1770412699.xml · derivative · entry 5 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 206,955 shares Expires 2026-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 21:18 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 132,410 | $362.42 | $47,988,032.20 |
DisclosureSEC source: 0001519419-26-000001 · wk-form4_1770412699.xml · nonDerivative · entry 2 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,940 Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 21:18 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 206,955 | $96.64 | $20,000,131.20 |
DisclosureSEC source: 0001519419-26-000001 · wk-form4_1770412699.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 329,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,782 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2025, the date of the latest available statement of the reporting person's ESPP holdings. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:18 UTC | STRYKER CORP SYK · Entity 369 | GrantEmployee Stock Option granted 02/04/2026 (right to buy) · Derivative | 58,206 | $0.00 Strike: $360.82 | $0.00 |
DisclosureSEC source: 0001519419-26-000001 · wk-form4_1770412699.xml · derivative · entry 4 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,206 Underlying: Common Stock · 58,206 shares Expires 2036-02-03 F2 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 21:01 UTC | Parker-Hannifin Corp PH · Entity 2887 | GiftCommon Stock | 2,048 | $0.00 | $0.00 |
DisclosureSEC source: 0000076334-25-000083 · form4.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,824 Read SEC document |
| October 22, 2025 Filed Oct 24, 2025 20:13 UTC | Parker-Hannifin Corp PH · Entity 2887 | GrantRestricted Stock Units | 258 | $0.00 | $0.00 |
DisclosureSEC source: 0000076334-25-000056 · form4.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,872 F1 · shares: Award of Restricted Stock Units on October 22, 2025 will vest on the later of (a) one year from the grant date; or (b) on the date of our next Annual Shareholders Meeting. F2 · balance_after: Includes 2 shares acquired as a dividend reinvestment feature under the Parker-Hannifin Corporation 2023 Omnibus Stock Incentive Plan. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 20:32 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionDividend Equivalents · Derivative | 1,085 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-25-000058 · wk-form4_1742934764.xml · derivative · entry 4 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,085 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 12, 2025, the Reporting Person filed a Form 4 reporting the acquisition of 44,507 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2025 (the "Performance Stock Units"). The 1,085 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2025 and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.exercise_date: On March 12, 2025, the Reporting Person filed a Form 4 reporting the acquisition of 44,507 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2025 (the "Performance Stock Units"). The 1,085 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2025 and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.expiration_date: On March 12, 2025, the Reporting Person filed a Form 4 reporting the acquisition of 44,507 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2025 (the "Performance Stock Units"). The 1,085 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2025 and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 20:32 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 23,321 | $374.22 | $8,727,184.62 |
DisclosureSEC source: 0000310764-25-000058 · wk-form4_1742934764.xml · nonDerivative · entry 2 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,304 Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 20:32 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 1,085 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-25-000058 · wk-form4_1742934764.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On March 12, 2025, the Reporting Person filed a Form 4 reporting the acquisition of 44,507 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2025 (the "Performance Stock Units"). The 1,085 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2025 and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 20:45 UTC | STRYKER CORP SYK · Entity 369 | GrantCommon Stock | 44,507 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-25-000031 · wk-form4_1741812315.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,540 F1 · kind: Acquired upon the achievement of pre-established three-year adjusted diluted net earnings per share goals and sales performance goals. The earned shares vest on March 21, 2025. F2 · balance_after: Includes 2,691 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2024, the date of the latest available statement of the reporting person's ESPP holdings. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 22:08 UTC | STRYKER CORP SYK · Entity 369 | GrantEmployee Stock Option granted 02/05/2025 (right to buy) · Derivative | 48,936 | $0.00 Strike: $392.39 | $0.00 |
DisclosureSEC source: 0000310764-25-000019 · wk-form4_1738966074.xml · derivative · entry 1 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,936 Underlying: Common Stock · 48,936 shares Expires 2035-02-04 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 21:16 UTC | Parker-Hannifin Corp PH · Entity 2887 | GiftCommon Stock | 3,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-019217 · form4.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,612 Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 21:20 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 2/11/2015 (right to buy) · Derivative | 156,890 | $0.00 Strike: $93.06 | $0.00 |
DisclosureSEC source: 0000310764-24-000118 · wk-form4_1731100803.xml · derivative · entry 7 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 156,890 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 21:20 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 15,866 | $369.75 | $5,866,453.50 |
DisclosureSEC source: 0000310764-24-000118 · wk-form4_1731100803.xml · nonDerivative · entry 5 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,027 F4 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $369.27 to $370.20, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 21:20 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 23,178 | $368.58 | $8,542,947.24 |
DisclosureSEC source: 0000310764-24-000118 · wk-form4_1731100803.xml · nonDerivative · entry 4 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,893 F3 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $368.21 to $369.20, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 21:20 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 18,269 | $367.95 | $6,722,078.55 |
DisclosureSEC source: 0000310764-24-000118 · wk-form4_1731100803.xml · nonDerivative · entry 3 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,071 F2 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $367.38 to $368.19, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 21:20 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 99,577 | $369.02 | $36,745,904.54 |
DisclosureSEC source: 0000310764-24-000118 · wk-form4_1731100803.xml · nonDerivative · entry 2 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,340 Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 21:20 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 156,890 | $93.06 | $14,600,183.40 |
DisclosureSEC source: 0000310764-24-000118 · wk-form4_1731100803.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,685 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of September 30, 2024, the date of the latest available statement of the reporting person's ESPP holdings. Read SEC document |
| October 23, 2024 Filed Oct 25, 2024 20:43 UTC | Parker-Hannifin Corp PH · Entity 2887 | GrantRestricted Stock Units | 299 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-017958 · form4.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,077 F1 · shares: Award of Restricted Stock Units on October 23, 2024 will vest on the later of (a) one year from the grant date; or (b) on the date of our next Annual Shareholders Meeting. F2 · balance_after: Includes 5 shares acquired as a dividend reinvestment feature under the Parker-Hannifin Corporation 2023 Omnibus Stock Incentive Plan. Read SEC document |
| October 23, 2024 Filed Apr 25, 2025 20:11 UTC Amendment | Parker-Hannifin Corp PH · Entity 2887 | GrantRestricted Stock Units | 299 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-008004 · form4a.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,077 F1 · shares: Award of Restricted Stock Units on October 23, 2024 will vest on the later of (a) one year from the grant date; or (b) on the date of our next Annual Shareholders Meeting. F2 · balance_after: Includes 5 shares acquired as a dividend reinvestment feature under the Parker-Hannifin Corporation 2023 Omnibus Stock Incentive Plan. Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 22:58 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionDividend Equivalents · Derivative | 905 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-24-000039 · wk-form4_1711407502.xml · derivative · entry 4 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 905 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 13, 2024, the Reporting Person filed a Form 4 reporting the acquisition of 37,773 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2024 (the "Performance Stock Units"). The 905 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2024 and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.exercise_date: On March 13, 2024, the Reporting Person filed a Form 4 reporting the acquisition of 37,773 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2024 (the "Performance Stock Units"). The 905 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2024 and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.expiration_date: On March 13, 2024, the Reporting Person filed a Form 4 reporting the acquisition of 37,773 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2024 (the "Performance Stock Units"). The 905 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2024 and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 22:58 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 19,785 | $353.19 | $6,987,864.15 |
DisclosureSEC source: 0000310764-24-000039 · wk-form4_1711407502.xml · nonDerivative · entry 2 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,934 Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 22:58 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 905 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-24-000039 · wk-form4_1711407502.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On March 13, 2024, the Reporting Person filed a Form 4 reporting the acquisition of 37,773 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2024 (the "Performance Stock Units"). The 905 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2024 and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 21:00 UTC | STRYKER CORP SYK · Entity 369 | GrantCommon Stock | 37,773 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-24-000033 · wk-form4_1710363594.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,814 F1 · kind: Acquired upon the achievement of pre-established three-year adjusted diluted net earnings per share goals and sales performance goals. The earned shares vest on March 21, 2024. F2 · balance_after: Includes 2,592 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2023, the date of the latest available statement of the reporting person's ESPP holdings. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 21:45 UTC | STRYKER CORP SYK · Entity 369 | GrantEmployee Stock Option granted 02/07/2024 (right to buy) · Derivative | 67,695 | $0.00 Strike: $339.77 | $0.00 |
DisclosureSEC source: 0000310764-24-000014 · wk-form4_1707515136.xml · derivative · entry 1 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,695 Underlying: Common Stock · 67,695 shares Expires 2034-02-06 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 22:18 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 02/12/2014 (right to buy) · Derivative | 160,215 | $0.00 Strike: $81.14 | $0.00 |
DisclosureSEC source: 0000310764-23-000121 · wk-form4_1700605120.xml · derivative · entry 8 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 160,215 shares Expires 2024-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 22:18 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 474 | $289.89 | $137,406.11 |
DisclosureSEC source: 0000310764-23-000121 · wk-form4_1700605120.xml · nonDerivative · entry 6 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,034 F5 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $289.81 to $289.99, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 22:18 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 8,060 | $289.12 | $2,330,284.63 |
DisclosureSEC source: 0000310764-23-000121 · wk-form4_1700605120.xml · nonDerivative · entry 5 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,508 F4 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $288.77 to $289.76, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 22:18 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 15,092 | $288.26 | $4,350,407.85 |
DisclosureSEC source: 0000310764-23-000121 · wk-form4_1700605120.xml · nonDerivative · entry 4 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,568 F3 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $287.77 to $288.76, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 22:18 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 32,857 | $287.42 | $9,443,712.94 |
DisclosureSEC source: 0000310764-23-000121 · wk-form4_1700605120.xml · nonDerivative · entry 3 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,660 F2 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $286.77 to $287.76, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 22:18 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 103,732 | $291.55 | $30,243,064.60 |
DisclosureSEC source: 0000310764-23-000121 · wk-form4_1700605120.xml · nonDerivative · entry 2 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,517 Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 22:18 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 160,215 | $81.14 | $12,999,845.10 |
DisclosureSEC source: 0000310764-23-000121 · wk-form4_1700605120.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,585 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of September 30, 2023, the date of the latest available statement of the reporting person's ESPP holdings. Read SEC document |
| October 25, 2023 Filed Oct 27, 2023 20:11 UTC | Parker-Hannifin Corp PH · Entity 2887 | GrantRestricted Stock Units | 453 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-019766 · form4.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,773 F1 · shares: Award of Restricted Stock Units on October 25, 2023 will vest on the later of (a) one year from the grant date; or (b) on the date of our next Annual Shareholders Meeting. F2 · balance_after: Includes 10 shares acquired as a dividend reinvestment feature under the Parker-Hannifin Corporation Amended and Restated 2016 Omnibus Stock Incentive Plan. Read SEC document |
| June 09, 2023 Filed Jun 16, 2023 00:43 UTC Amendment | STRYKER CORP SYK · Entity 369 | GiftCommon Stock | 8,904 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-23-000099 · wk-form4a_1686876223.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,959 F1 · date: This amendment is being filed solely to correct the transaction date for the gift, which was incorrectly reported as June 5, 2023 on the original Form 4. The transaction occurred on June 9, 2023. F2 · balance_after: Includes 2,510 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of March 31, 2023, the date of the latest available statement of the reporting person's ESPP holdings. Read SEC document |
| June 05, 2023 Filed Jun 13, 2023 21:22 UTC | STRYKER CORP SYK · Entity 369 | GiftCommon Stock | 8,904 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-23-000097 · wk-form4_1686691334.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,959 F1 · balance_after: Includes 2,510 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of March 31, 2023, the date of the latest available statement of the reporting person's ESPP holdings. Read SEC document |
| March 21, 2023 Filed Mar 23, 2023 23:00 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionDividend Equivalents · Derivative | 504 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-23-000043 · wf-form4_167961241234983.xml · derivative · entry 4 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 504 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 9, 2023, the Reporting Person filed a Form 4 reporting the acquisition of 17,971 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2023 (the "Performance Stock Units"). The 504 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2023 and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.exercise_date: On March 9, 2023, the Reporting Person filed a Form 4 reporting the acquisition of 17,971 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2023 (the "Performance Stock Units"). The 504 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2023 and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.expiration_date: On March 9, 2023, the Reporting Person filed a Form 4 reporting the acquisition of 17,971 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2023 (the "Performance Stock Units"). The 504 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2023 and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 21, 2023 Filed Mar 23, 2023 23:00 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 9,425 | $276.83 | $2,609,122.75 |
DisclosureSEC source: 0000310764-23-000043 · wf-form4_167961241234983.xml · nonDerivative · entry 2 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,828 Read SEC document |
| March 21, 2023 Filed Mar 23, 2023 23:00 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 504 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-23-000043 · wf-form4_167961241234983.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On March 9, 2023, the Reporting Person filed a Form 4 reporting the acquisition of 17,971 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2023 (the "Performance Stock Units"). The 504 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2023 and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 23:14 UTC | STRYKER CORP SYK · Entity 369 | GrantCommon Stock | 17,971 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-23-000034 · wf-form4_167840362899333.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,749 F1 · kind: Acquired upon the achievement of pre-established three-year adjusted diluted net earnings per share goals and sales performance goals. The earned shares vest on March 21, 2023. F2 · balance_after: Includes 2,475 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2022, the date of the latest available statement of the reporting person's ESPP holdings. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:17 UTC | STRYKER CORP SYK · Entity 369 | GrantEmployee Stock Option granted 02/09/2023 (right to buy) · Derivative | 100,665 | $0.00 Strike: $268.22 | $0.00 |
DisclosureSEC source: 0000310764-23-000025 · wf-form4_167632660847326.xml · derivative · entry 1 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,665 Underlying: Common Stock · 100,665 shares Expires 2033-02-08 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 00:09 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 02/13/2013 (right to buy) · Derivative | 187,470 | $64.01 Strike: $64.01 | $11,999,954.70 |
DisclosureSEC source: 0000310764-22-000116 · wf-form4_167028536673114.xml · derivative · entry 6 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 187,470 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 00:09 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 23,423 | $240.16 | $5,625,267.68 |
DisclosureSEC source: 0000310764-22-000116 · wf-form4_167028536673114.xml · nonDerivative · entry 4 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,770 F3 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $240.015 to $240.36, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 00:09 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 43,809 | $239.43 | $10,489,031.16 |
DisclosureSEC source: 0000310764-22-000116 · wf-form4_167028536673114.xml · nonDerivative · entry 3 Lobo Kevin · CIK 0001519419 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,193 F2 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $239.00 to $239.925, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.